‘Duty-To-Warn’ in the Digital Era: Emerging Issues
January 25, 2012
Manufacturers have a legal responsibility to communicate the known risks associated with their medications and ‘duty-to-warn’ responsibilities have traditionally been fulfilled by publishing labeling information online or in reference texts.
However, as physician workflow consolidates around electronic health record systems, manufacturers may increasingly find themselves under scrutiny regarding their ‘duty-to-warn’ efforts – how and where they provide safety messaging will make the difference.
This webinar will include information regarding:
- ‘Duty-to-warn’ relating to medical malpractice litigation and product liability management, including an update on the Supreme Court’s recent cases and the impact on Generics
- The increasing role of technology in the evolution of ‘duty-to-warn’ benchmarking
- The growing responsibility on regulatory and marketing operations regarding ‘duty-to-warn’ in healthcare IT systems
- The importance of labeling information in the physician’s electronic workflow